BioCardia, Inc.

Nasdaq:BCDA

Biological Products, (No Diagnostic Substances)·SUNNYVALE, CA

CEO

Altman Peter

CFO

Mcclung David

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q/A	Q2 2025	6/30/25	10/29/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/26/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

Earnings Releases (8-K)

9 shown

Filed	Period
11/12/25	Q4 FY2025	→
8/11/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
3/26/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
8/13/24	Q3 FY2024	→
↓

News (8-K)

71 shown

Filed	Type	Description
3/3/26	Reg FD	Regulation FD Disclosure	→
2/10/26	Other	Other Events	→
2/3/26	Other	Other Events	→
12/16/25	Reg FD	Regulation FD Disclosure	→
12/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/24/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/18/25	S-8	S-8	→
10/24/25	424B5	424B5	→
9/19/25	424B4	424B4	→
9/17/25	S-1/A	FORM S-1/A	→
9/16/25	S-1	S-1	→
7/9/25	S-3	S-3	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

8-K

Mar 3, 2026

0001437749-26-006481FORM 8-K

Mar 3, 2026

175.7 KB

8-K

Feb 10, 2026

0001437749-26-003582FORM 8-K

Feb 10, 2026

175.7 KB

Feb 4, 2026

0001437749-26-003027FORM 4

Feb 4, 2026

4.4 KB

8-K

Feb 3, 2026

0001437749-26-002723FORM 8-K

Feb 3, 2026

164.6 KB

Jan 21, 2026

0001437749-26-001643FORM 4

Jan 20, 2026

6.7 KB

S-8

Dec 18, 2025

0001437749-25-038318FORM S-8

—

329.0 KB

Dec 17, 2025

0001437749-25-038200FORM 4

Dec 16, 2025

6.7 KB

8-K

Dec 16, 2025

0001437749-25-037910FORM 8-K

Dec 16, 2025

178.0 KB

Dec 10, 2025

0001437749-25-037475FORM 4

Dec 8, 2025

8.8 KB

Dec 10, 2025

0001437749-25-037474FORM 4

Dec 8, 2025

8.7 KB

Dec 10, 2025

0001437749-25-037473FORM 4

Dec 8, 2025

8.7 KB

Dec 10, 2025

0001437749-25-037472FORM 4

Dec 8, 2025

5.2 KB

Dec 10, 2025

0001437749-25-037471FORM 4

Dec 8, 2025

5.2 KB

Dec 10, 2025

0001437749-25-037470FORM 4

Dec 8, 2025

5.2 KB

Dec 10, 2025

0001437749-25-037469FORM 4

Dec 8, 2025

5.3 KB

Dec 10, 2025

0001437749-25-037468FORM 4

Dec 8, 2025

5.2 KB

Dec 10, 2025

0001437749-25-037467FORM 4

Dec 8, 2025

5.2 KB

Dec 10, 2025

0001437749-25-037466FORM 3

Dec 2, 2025

11.4 KB

8-K

Dec 3, 2025

0001437749-25-036711FORM 8-K

Dec 2, 2025

201.9 KB

8-K

Nov 24, 2025

0001437749-25-036076FORM 8-K

Nov 24, 2025

165.8 KB

8-K

Nov 12, 2025

0001437749-25-034442FORM 8-K

Nov 12, 2025

280.2 KB

10-Q

Nov 12, 2025

0001437749-25-034437FORM 10-Q

Sep 30, 2025

4.1 MB

8-K

Nov 10, 2025

0001437749-25-033949FORM 8-K

Nov 10, 2025

169.9 KB

DEF 14A

Nov 3, 2025

0001437749-25-032661FORM DEF 14A

Dec 2, 2025

2.0 MB

8-K

Oct 30, 2025

0001437749-25-032289FORM 8-K

Oct 30, 2025

169.6 KB

25 filings shown

Filed	Form	Description
9/24/25	SCHEDULE 13G	SCHEDULE 13G	→
9/19/25	SCHEDULE 13G	SCHEDULE 13G	→
9/18/25	EFFECT	EFFECT	→
8/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/17/25	EFFECT	EFFECT	→
7/17/25	EFFECT	EFFECT	→
↓

BioCardia, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/3/25	DEF 14A	DEF 14A	→
4/15/24	DEF 14A	DEF 14A	→
4/4/24	PRE 14A	FORM PRE 14A	→
9/1/23	DEF 14A	DEF 14A	→
4/27/22	DEF 14A	DEF 14A	→
4/30/21	DEFA14A	FORM DEFA14A	→
↓

Filed	Form	Description
2/4/26	4	4	→
1/21/26	4	4	→
12/17/25	4	4	→
12/10/25	4	4	→
12/10/25	4	4	→
12/10/25	4	4	→
↓